melissa waggener zorkin founder WE

Corporate Reputation & Brand Purpose

Overcoming the Lack of Diversity in Clinical Trials

May 21, 2024 | Christina Corso, Executive Vice President, Health, Jocelyn Jackson, Senior Director, Insights & Analytics

Is Corporate Purpose Still Relevant in 2024?

March 28, 2024 | Libby Woolnough, Group Head - Corporate Reputation & Brand Purpose, WE Communications Australia

ESG Is Now Essential to B2B Business Success in China

January 22, 2024 | Nicky Wang, CEO, WE Red Bridge

Tech, Trials and Temperatures

November 09, 2023 | Shannon O’Shea, Senior Vice President of Environmental Sustainability, US

Why Sustainability and Transparency Go Hand in Hand

August 01, 2023 | Libby Woolnough, Group Head - Corporate Reputation & Brand Purpose, WE Communications Australia

Break Down Silos to Advance Sustainability

June 20, 2023 | Rebecca Wilson, former EVP, International

Healthy Reputations: The Foundation of Biotech and Pharma Firms’ Future

April 25, 2023 | Nitin Mantri, Regional Executive Managing Director for Asia-Pacific, WE and Group CEO, Avian WE

How a Strong Corporate Reputation Drives Healthcare Business

March 13, 2023 | Stephanie Marchesi, President, Global Health and NA Eastern Region

Insulin Price Move Demonstrates the Power of Patient Centricity

March 09, 2023 | Stephanie Marchesi, President, Global Health and NA Eastern Region

The Top ESG Trends We're Watching 2023

February 23, 2023 | Shannon O’Shea, Senior Vice President of Environmental Sustainability, US, Courtney Urban, SVP, Corporate Reputation and Brand Purpose
Load more